Both in Biotechnology
Humacyte vs Voyager Therapeutics
Over the past year HUMA returned −72.3% and VYGR returned −60.1%; their daily moves had a correlation of 0.21.
HUMA −72.3% VYGR −60.1%Growth of $1, one year, split-adjusted
| Metric | HUMA | VYGR |
|---|---|---|
| Price | $0.4405 | $1.83 |
| Market cap | $122.4M | $112.8M |
| Today | +10.65% | +2.81% |
| 1 month | −11.9% | −25.6% |
| 6 months | −51.2% | −53.1% |
| Year to date | −54.1% | −53.4% |
| 1 year | −73.6% | −60.8% |
| Revenue growth (YoY) | +34.9% | −39.1% |
| Gross margin | −203.2% | 100.0% |
| Net margin | −9064.5% | −773.2% |
| P/E (TTM) | — | — |
| Price / sales | 57.7× | 3.3× |
| Net cash | $13.7M | $116.3M |
| Dividend yield | — | — |
| Volatility (60d) | 108.0% | 60.9% |
| Short % of float | 11.9% | 7.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).